Dr Hamzavi discussed how to navigate conversations with patients with HS regarding common misconceptions, expectations with ...

HealthDay News — Updated recommendations are presented for the management of urinary tract infections (UTIs) in infants and children younger than 5 years in a clinical practice guideline (CPG) issued ...

Guidelines present first-, second-, and third-line treatments and emphasize use of an informed decision-making approach ...

Real-world GPP data show low uptake of targeted IL-36 inhibitors and persistent reliance on corticosteroids and non-GPP ...

Real-world data from Fall Clinical 2026 reveal widespread treatment dissatisfaction, anxiety, and steroid hesitancy among ...

Risk for ischemic stroke, myocardial infarction were increased with prolonged use with doses >1 mg/day for more than one year ...

Dr Ablon discusses important key points providers should keep in mind during their evaluations of patients seeking aesthetic ...

The novel oral helicase-primase inhibitor offers a non-intravenous option for immunocompromised adults with mucocutaneous HSV refractory to standard antivirals.

Holding meds does not enhance humoral immunogenicity and is associated with disease flares for patients with inflammatory arthritis ...

BRAVE-AA-PEDS data presented at FC26 show baricitinib maintained significant hair regrowth through 76 weeks in adolescents with severe alopecia areata.

Statin treatment also associated with lower risks for treatment escalation, including surgery, topical ocular hypotensive prescription.

"Because evidence on GLP-1 exposure during breastfeeding remains limited, rising postpartum initiation warrants further study." HealthDay News — Postpartum initiation of glucagon-like peptide-1 ...